UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 202

Sortiert nach

Genetic and phenotypic characterisation of HIV‐associated aggressive B‐cell non‐Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications

Histopathology, 2022-12, Vol.81 (6), p.826-840

2022

Volltextzugriff (PDF)

Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone: A New, Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2009-09, Vol.27 (27), p.4578-4584

2009

Volltextzugriff (PDF)

MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by α4β1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration

Blood, 2006-11, Vol.108 (9), p.3143-3151

2006

Volltextzugriff (PDF)

A risk‐adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study

Transplant infectious disease, 2017-08, Vol.19 (4), p.n/a

2017

Volltextzugriff (PDF)

Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration

Blood, 2008-01, Vol.111 (1), p.383-386

2008

Volltextzugriff (PDF)

Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients

Annals of hematology, 2022-09, Vol.101 (9), p.2053-2067

2022

Volltextzugriff (PDF)

Monosomal karyotype in chronic lymphocytic leukemia: Association with clinical and biological features and potential prognostic significance

American journal of hematology, 2017-07, Vol.92 (7), p.E132-E135

2017

Volltextzugriff (PDF)

PB2314: CYTOPENIAS AND BLOOD TRANSFUSION SUPPORT AFTER CAR‐T THERAPY

HemaSphere, 2023-08, Vol.7 (S3), p.e3405129-n/a

2023

Volltextzugriff (PDF)

Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups

Leukemia & lymphoma, 2009, Vol.50 (1), p.68-79

2009

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor (VEGF) Increases B-CLL CELL Migration Through Regulation of CXCR4/SDF1 AXIS

Blood, 2012-11, Vol.120 (21), p.3917-3917

2012

Volltextzugriff (PDF)

Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma

Haematologica (Roma), 2020-08, Vol.105 (8), p.e408

2020

Volltextzugriff (PDF)

A 17-residue Sequence from the Matrix Metalloproteinase-9 (MMP-9) Hemopexin Domain Binds α4β1 Integrin and Inhibits MMP-9-induced Functions in Chronic Lymphocytic Leukemia B Cells

The Journal of biological chemistry, 2012-08, Vol.287 (33), p.27601-27613

2012

Volltextzugriff (PDF)

Rituximab, Bendamustine, Mitoxantrone, Dexamethasone (R-BMD) in Patients with Follicular Lymphoma in Relapse or Refractory to First-Line Treatment with Immunochemotherapy. R-BMD Geltamo 08 Trial

Blood, 2012-11, Vol.120 (21), p.1639-1639

2012

Volltextzugriff (PDF)

In the literature: February 2017

ESMO open, 2017, Vol.2 (1), p.e000171-e000171, Article e000171

2017

Volltextzugriff (PDF)

The FLIPI2 SCORE Predicts PROGRESSION-FREE SURVIVAL (PFS) and OVERALL SURVIVAL (OS) IN AN INDEPENDENT SERIES of Follicular LYMPHOMA: A Single Institution EXPERIENCE

Blood, 2010-11, Vol.116 (21), p.3128-3128

2010

Volltextzugriff (PDF)

RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group

Annals of hematology, 2020-04, Vol.99 (4), p.799-808

2020

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(83)
Life Sciences & Biomedicine
(81)
Humans
(75)
Female
(50)
Male
(50)
Middle Aged
(47)
Aged
(46)
Hematology
(43)
Adult
(30)
Oncology
(27)
Aged, 80 And Over
(20)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Hematologic And Hematopoietic Diseases
(19)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(19)
Prognosis
(17)
Treatment Outcome
(13)
Chronic Lymphocytic Leukemia
(12)
Leukemia, Lymphocytic, Chronic, B-Cell - Genetics
(12)
Risk Factors
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma

SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

Genetic and phenotypic characterisation of HIV‐associated aggressive B‐cell non‐Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications

Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial

Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone: A New, Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia

MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by α4β1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration

A risk‐adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study

Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration

Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients

Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma

Monosomal karyotype in chronic lymphocytic leukemia: Association with clinical and biological features and potential prognostic significance

Response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first‐line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression

Multiparameter Flow Cytometry Evaluation of Plasma Cell DNA Content and Proliferation in 595 Transplant-Eligible Patients with Myeloma Included in the Spanish GEM2000 and GEM2005<65y Trials

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia

PB2314: CYTOPENIAS AND BLOOD TRANSFUSION SUPPORT AFTER CAR‐T THERAPY

Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups

Vascular Endothelial Growth Factor (VEGF) Increases B-CLL CELL Migration Through Regulation of CXCR4/SDF1 AXIS

Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma

A 17-residue Sequence from the Matrix Metalloproteinase-9 (MMP-9) Hemopexin Domain Binds α4β1 Integrin and Inhibits MMP-9-induced Functions in Chronic Lymphocytic Leukemia B Cells

Rituximab, Bendamustine, Mitoxantrone, Dexamethasone (R-BMD) in Patients with Follicular Lymphoma in Relapse or Refractory to First-Line Treatment with Immunochemotherapy. R-BMD Geltamo 08 Trial

In the literature: February 2017

The FLIPI2 SCORE Predicts PROGRESSION-FREE SURVIVAL (PFS) and OVERALL SURVIVAL (OS) IN AN INDEPENDENT SERIES of Follicular LYMPHOMA: A Single Institution EXPERIENCE

RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group

Suchergebnisse filtern